Astec Lifesciences Intrinsic Value
ASTEC Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹132.96 | ₹119.66 - ₹146.26 | -80.0% | Book Value/Share: ₹117.50, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹199.44 | ₹179.50 - ₹219.38 | -70.0% | Revenue/Share: ₹150.00, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹265.92 | ₹212.74 - ₹319.10 | -60.0% | CF Growth: 5.0%, Discount: 15% |
Want to compare with current market value? Check ASTEC share price latest .
Valuation Comparison Chart
ASTEC Intrinsic Value Analysis
What is the intrinsic value of ASTEC?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Astec Lifesciences (ASTEC) is ₹199.44 (median value). With the current market price of ₹664.80, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹132.96 to ₹265.92, indicating ₹132.96 - ₹265.92.
Is ASTEC undervalued or overvalued?
Based on our multi-method analysis, Astec Lifesciences (ASTEC) appears to be trading above calculated value by approximately 70.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.21 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 3.75 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | -40.9% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -9.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.34x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Astec Lifesciences
Additional stock information and data for ASTEC
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-8 Cr | ₹-16 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹10 Cr | ₹-58 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹75 Cr | ₹19 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹24 Cr | ₹-28 Cr | Positive Operating Cash Flow | 6/10 |
| March 2021 | ₹-8 Cr | ₹-45 Cr | Negative Cash Flow | 3/10 |